Nathan Standifer

Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases

Christine Beeton, Heike Wulff, Nathan Standifer et al. · Proceedings of the National Academy of Sciences · 2006 · 538 citations

Life Sciences, Cell Biology, Immunology +17

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Robin Kate Kelley, Bruno Sangro, William Proctor Harris et al. · Journal of Clinical Oncology · 2021 · 438 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani et al. · Leukemia · 2018 · 247 citations · Full text

Medicine, Oncology, Pharmacology +16

Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells

Francesco Vendrame, Antonello Pileggi, Elsa M. Laughlin et al. · Diabetes · 2010 · 210 citations · Full text

Life Sciences, Endocrinology, Immunology +17

ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors

Paul L. Bollyky, Rebecca P. Wu, Ben Falk et al. · Proceedings of the National Academy of Sciences · 2011 · 140 citations · Full text

Life Sciences, Cell Biology, Immunology +17